Radiopharm Theranostics (RADX)

• Market cap: $40.9M
• 1 day: 1.74%
• 5 days: 0%
• 1 month: -4.71%
• 3 months: 11.91%
• 6 months: 34.53%
• Year to date: 13.36%
• 1 year: -70.23%
• 5 years: -70.23%
• 10 years: -70.23%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.